Sonora Investment Management Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$6.97M Sell
24,707
-1,136
-4% -$329K 0.49% 57
2025
Q2
$7.22M Sell
25,843
-88
-0.3% -$24.9K 0.54% 55
2025
Q1
$8.08M Sell
25,931
-911
-3% -$269K 0.64% 53
2024
Q4
$7M Sell
26,842
-370
-1% -$110K 0.54% 59
2024
Q3
$8.77M Sell
27,212
-114
-0.4% -$37.3K 0.65% 56
2024
Q2
$7.77M Hold
27,326
0.61% 60
2024
Q1
$7.77M Buy
27,326
+51
+0.2% +$14.9K 0.61% 60
2023
Q4
$7.86M Sell
27,275
-134
-0.5% -$36.5K 0.64% 57
2023
Q3
$7.37M Sell
27,409
-106
-0.4% -$26.5K 0.63% 58
2023
Q2
$6.11M Sell
27,515
-936
-3% -$217K 0.51% 71
2023
Q1
$6.88M Sell
28,451
-712
-2% -$175K 0.6% 63
2022
Q4
$7.66M Buy
29,163
+1,166
+4% +$313K 0.7% 56
2022
Q3
$6.81M Hold
27,997
0.88% 47
2022
Q2
$6.81M Buy
27,997
+807
+3% +$198K 0.65% 62
2022
Q1
$6.58M Buy
27,190
+212
+0.8% +$48.7K 0.74% 52
2021
Q4
$6.07M Buy
+26,978
New +$5.69M 0.7% 53

Other funds holding AMGN

Sonora Investment Management Group's AMGN Position: Q3 2025 in Review

Sonora Investment Management Group reduced its Amgen (AMGN) stake by 4.4% in Q3 2025, selling an estimated $329K and leaving 24,707 shares worth $6.97M. The position accounts for 0.49% of the portfolio, ranked #57.

Sonora Investment Management Group first reported a position in AMGN in Q4 2021 and has held it in 16 quarters since. The position peaked at $8.77M in Q3 2024. 2,820 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Sonora Investment Management Group held 24,707 shares of Amgen worth $6.97M as of Q3 2025.
  • Sonora Investment Management Group sold 1,136 Amgen shares in Q3 2025, an estimated $329K.
  • Amgen made up 0.49% of Sonora Investment Management Group's portfolio in Q3 2025, its #57 holding.
  • Sonora Investment Management Group first reported a position in Amgen in Q4 2021 and has held it in 16 quarters since.
  • Sonora Investment Management Group's Amgen position peaked at $8.77M in Q3 2024.
  • 2,820 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Sonora Investment Management Group's 13F filing for Q3 2025, filed 7 Oct 2025.